Levitz, D., Gutierrez, M., Winer, I. S., Reilley, M., Duska, L. R., Subbiah, V., Richardson, D. L., Bohac, C., CHIARELLA, M., Naranjo, C., Kanodia, J., Woo, J., Nevadunsky, N. (2025). A phase 1, first-in-human, dose escalation and expansion study to evaluate the safety and tolerability of XmAb541 (claudin-6 x CD3) T-cell engaging bispecific antibody in subjects with germ cell tumors and other advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps652